Ko HW - Search Results

1

Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.

Nie L, Wang YN, Hsu JM, Hou J, Chu YY, Chan LC, Huo L, Wei Y, Deng R, Tang J, Hsu YH, Ko HW, Lim SO, Huang K, Chen MK, Chiu TJ, Cheng CC, Fang YF, Li CW, Goverdhan A, Wu HJ, Lee CC, Wang WL, Hsu J, Chiao P, Wang SC, Hung MC. Nie L, et al. Among authors: ko hw. Am J Cancer Res. 2023 Apr 15;13(4):1209-1239. eCollection 2023. Am J Cancer Res. 2023. PMID: 37168336 Free PMC article.

2

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations.

Liu CY, Wang CL, Li SH, Hsu PC, Chen CH, Lin TY, Kuo CH, Fang YF, Ko HW, Yu CT, Yang TY, Yang CT. Liu CY, et al. Among authors: ko hw. Oncotarget. 2017 Jun 27;8(57):97602-97612. doi: 10.18632/oncotarget.18746. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228636 Free PMC article.

3

Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort study.

Lu CW, Wang TY, Yen CF, Chen KH, Wu CE, Wang CL, Hsu PC, Fang YF, Li SH, Ko HW, Tseng LC, Shih FY, Lin YJ, Chen MJ, Chen CB, Su Pang JH, Chung WH, Ko YS. Lu CW, et al. Among authors: ko ys, ko hw. Int J Dermatol. 2021 Feb;60(2):179-184. doi: 10.1111/ijd.15099. Epub 2020 Sep 25. Int J Dermatol. 2021. PMID: 32975313

4

Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma.

Lu CW, Pang JS, Ko YS, Chang CJ, Wang CW, Chen WT, Chen CB, Hui RC, Hung SI, Lu LY, Lu KL, Wang CL, Wu CE, Hsu PC, Fang YF, Li SH, Ko HW, Tseng LC, Shih FY, Chen MJ, Chung WH. Lu CW, et al. Among authors: ko ys, ko hw. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):328-339. doi: 10.1111/jdv.18703. Epub 2022 Nov 16. J Eur Acad Dermatol Venereol. 2023. PMID: 36366861

5

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC.

Ju JS, Huang AC, Tung PH, Huang CH, Chiu TH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Ju JS, et al. Among authors: ko hw. Sci Rep. 2023 Nov 21;13(1):20323. doi: 10.1038/s41598-023-45815-8. Sci Rep. 2023. PMID: 37989860 Free PMC article.

6

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.

Tung PH, Chiu TH, Huang AC, Ju JS, Huang CH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Tung PH, et al. Among authors: ko hw. Ther Adv Med Oncol. 2024 Jan 19;16:17588359231222604. doi: 10.1177/17588359231222604. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38249338 Free PMC article.

7

Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.

Chiu LC, Hsu PC, Wang CC, Ko HW, Kuo SC, Ju JS, Tung PH, Huang AC, Yang CT. Chiu LC, et al. Among authors: ko hw. Thorac Cancer. 2024 Mar;15(7):529-537. doi: 10.1111/1759-7714.15212. Epub 2024 Jan 26. Thorac Cancer. 2024. PMID: 38279515 Free PMC article.

8

Targeted Sequencing of Circulating Cell Free DNA Can Be Used to Monitor Therapeutic Efficacy of Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients.

Chiou CC, Wang CL, Luo JD, Liu CY, Ko HW, Yang CT. Chiou CC, et al. Among authors: ko hw. Cancer Genomics Proteomics. 2020 Jul-Aug;17(4):417-423. doi: 10.21873/cgp.20200. Cancer Genomics Proteomics. 2020. PMID: 32576586 Free PMC article.

9

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab.

Ko HW, Chiu CT, Wang CL, Yang TY, Liu CY, Yu CT, Tseng LC, Kuo CS, Wang CC, Yang MH, Yang CT. Ko HW, et al. Cancers (Basel). 2022 Jul 17;14(14):3470. doi: 10.3390/cancers14143470. Cancers (Basel). 2022. PMID: 35884531 Free PMC article.

10

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation.

Ko HW, Shie SS, Wang CW, Chiu CT, Wang CL, Yang TY, Chou SC, Liu CY, Kuo CS, Lin YC, Li LF, Yang CT, Wang CC. Ko HW, et al. Front Immunol. 2022 Oct 20;13:1011092. doi: 10.3389/fimmu.2022.1011092. eCollection 2022. Front Immunol. 2022. PMID: 36341427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page